# Tiotropium

## Spiriva Respimat 2.5mcg/puff

| 藥物代碼           | ESPIR                                                                                                                                                                                                                                                                                 |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Maintenance treatment of patients with COPD (including chronic bronchitis & emphysema).                                                                                                                                                                                               |
| 副作用             | GI disturbances, cough & local irritation, dysuria, urinary retention (in men), tachycardia, allergic reactions.Gastrointestinal: Constipation (4% ), Xerostomia (12% to 16% )Respiratory: Pharyngitis (7% to 9% ), Sinusitis (3% to 11% ), Upper respiratory infection (41% to 43% ) |
| 禁忌               | Patients with a history of hypersensitivity to atropine or its derivatives eg, ipratropium or oxitropium, or to any component of Spiriva.                                                                                                                                             |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                  |
| 用法用量           | Adult: Inhale 2 puffs once daily from the RESPIMAT inhaler at the same time of day.                                                                                                                                                                                                   |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                          |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                          |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                        |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest low risk                                                                                                                                                                                                                                |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                   |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                   |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                   |
| 注射劑給藥建議途徑 | IH, INHL                                                                                                                                                                                                                                                                              |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                   |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                   |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                   |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                   |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                   |

